Free Trial

SG Americas Securities LLC Purchases 14,719 Shares of Azenta, Inc. (NASDAQ:AZTA)

Azenta logo with Medical background

SG Americas Securities LLC increased its position in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 90.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 30,972 shares of the company's stock after acquiring an additional 14,719 shares during the quarter. SG Americas Securities LLC owned about 0.07% of Azenta worth $1,073,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. KLP Kapitalforvaltning AS purchased a new position in shares of Azenta in the fourth quarter valued at about $530,000. Deutsche Bank AG raised its stake in Azenta by 28.5% during the 4th quarter. Deutsche Bank AG now owns 4,199 shares of the company's stock valued at $210,000 after purchasing an additional 931 shares during the period. Thrivent Financial for Lutherans lifted its holdings in Azenta by 206.5% in the 4th quarter. Thrivent Financial for Lutherans now owns 35,223 shares of the company's stock worth $1,761,000 after purchasing an additional 23,731 shares in the last quarter. Proficio Capital Partners LLC purchased a new position in Azenta in the 4th quarter worth approximately $910,000. Finally, State of New Jersey Common Pension Fund D boosted its stake in Azenta by 28.3% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 51,312 shares of the company's stock worth $2,566,000 after purchasing an additional 11,304 shares during the period. Institutional investors own 99.08% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on AZTA shares. TD Cowen upgraded shares of Azenta to a "hold" rating in a research report on Thursday, February 27th. Needham & Company LLC reduced their price target on shares of Azenta from $59.00 to $40.00 and set a "buy" rating on the stock in a report on Wednesday, May 7th.

Read Our Latest Stock Analysis on AZTA

Azenta Price Performance

Shares of NASDAQ AZTA traded up $0.63 during mid-day trading on Thursday, hitting $29.94. 776,543 shares of the company's stock traded hands, compared to its average volume of 701,706. Azenta, Inc. has a 1 year low of $23.91 and a 1 year high of $63.58. The company's 50-day moving average is $27.41 and its two-hundred day moving average is $39.02. The company has a market capitalization of $1.37 billion, a P/E ratio of -21.54 and a beta of 1.62.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a positive return on equity of 1.30% and a negative net margin of 10.31%. The firm's revenue was up 5.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.06 EPS. Equities analysts anticipate that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

About Azenta

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Read More

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Should You Invest $1,000 in Azenta Right Now?

Before you consider Azenta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.

While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines